Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1;La expresión de microARN-133 inhibe la transición epitelio-mesenquimatosa en las células del cáncer de pulmón apuntando directamente al FOXQ1

Archivos de Bronconeumologia

Volumn 52, Issue 10, 2016, Pages 505-511

  Xiao, Bo ^a,b   Liu, Huazhen ^a   Gu, Zeyun ^a   Ji, Cheng ^a  

^a SOOCHOW UNIVERSITY   (China)

^b YANCHENG INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Epithelial mesenchymal transition; FOXQ1; Lung cancer; MicroRNA 133; TGF

Indexed keywords

MICRORNA; MICRORNA 133; PEPTIDES AND PROTEINS; PROTEIN FOXQ1; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CADHERIN; CDH1 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXQ1 PROTEIN, HUMAN; MIRN133 MICRORNA, HUMAN; RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN; FORKHEAD FACTOR FOXQ1; TRANSCRIPTION FACTOR;

ARTICLE; CELL INVASION; CELL MIGRATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; LUNG CANCER; LUNG CANCER CELL LINE; LUNG CARCINOGENESIS; METASTASIS; PROTEIN EXPRESSION; TUMOR INVASION; 3' UNTRANSLATED REGION; BIOSYNTHESIS; CELL ADHESION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN CELL; PROTEIN RNA BINDING; PROTEIN TARGETING; BINDING SITE; DISEASE ASSOCIATION; MIGRATION INHIBITION;

3' UNTRANSLATED REGIONS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 85027224931     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2016.01.015     Document Type: Article

References (29)

1. 1 Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA Cancer J Clin. 62 (2012), 10–29.
2. 2 Castellanos, J.A., Merchant, N.B., Nagathihalli, N.S., Emerging targets in pancreatic cancer: Epithelial-mesenchymal transition and cancer stem cells. Onco Targets Ther. 6 (2013), 1261–1267.
3. 3 Thiery, J.P., Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2 (2002), 442–454.
4. 4 Lamouille, S., Xu, J., Derynck, R., Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15 (2014), 178–196.
5. 5 Thiery, J.P., Acloque, H., Huang, R.Y., Nieto, M.A., Epithelial-mesenchymal transitions in development and disease. Cell. 139 (2009), 871–890.
6. 6 Qiao, Y., Jiang, X., Lee, S.T., Karuturi, R.K., Hooi, S.C., Yu, Q., FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res. 71 (2011), 3076–3086.
7. 7 Peng, X., Luo, Z., Kang, Q., Deng, D., Wang, Q., Peng, H., et al. FOXQ1 mediates the crosstalk between TGF-beta and Wnt signaling pathways in the progression of colorectal cancer. Cancer Biol Ther. 16 (2015), 1099–1109.
8. 8 Feng, J., Zhang, X., Zhu, H., Wang, X., Ni, S., Huang, J., FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS One., 7, 2012, e39937.
9. 9 Feng, J., Xu, L., Ni, S., Gu, J., Zhu, H., Wang, H., et al. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity. Oncotarget. 5 (2014), 9689–9702.
10. 10 Bartel, D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116 (2004), 281–297.
11. 11 Bartel, D.P., MicroRNAs: Target recognition and regulatory functions. Cell. 136 (2009), 215–233.
12. 12 Wang, Z., Li, Y., Ahmad, A., Azmi, A.S., Kong, D., Banerjee, S., et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat. 13 (2010), 109–118.
13. 13 Li, J., Yang, S., Yan, W., Yang, J., Qin, Y.J., Lin, X.L., et al. MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition. Lab Invest. 95 (2015), 1056–1070.
14. 14 Liu, M.X., Zhou, K.C., Cao, Y., MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Mol Cancer., 13, 2014, 245.
15. 15 Zhong, Z., Xia, Y., Wang, P., Liu, B., Chen, Y., Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer. Mol Med Rep. 10 (2014), 2575–2579.
16. 16 Fan, D.M., Feng, X.S., Qi, P.W., Chen, Y.W., Forkhead factor FOXQ1 promotes TGF-beta1 expression and induces epithelial-mesenchymal transition. Mol Cell Biochem. 397 (2014), 179–186.
17. 17 Shi, Y., Massague, J., Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113 (2003), 685–700.
18. 18 Kitamura, K., Seike, M., Okano, T., Matsuda, K., Miyanaga, A., Mizutani, H., et al. MiR-134/487b/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther. 13 (2014), 444–453.
19. 19 Jiang, L., He, D., Yang, D., Chen, Z., Pan, Q., Mao, A., et al. MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway. FEBS Lett. 588 (2014), 2009–2015.
20. 20 Yang, Q., Wang, Y., Lu, X., Zhao, Z., Zhu, L., Chen, S., et al. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells. Oncotarget. 6 (2015), 3268–3279.
21. 21 Shien, K., Toyooka, S., Yamamoto, H., Soh, J., Jida, M., Thu, K.L., et al. Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res. 73 (2013), 3051–3061.
22. 22 Xia, H., Ooi, L.L., Hui, K.M., MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology. 58 (2013), 629–641.
23. 23 Zhang, W., Liu, K., Liu, S., Ji, B., Wang, Y., Liu, Y., MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumour Biol 36 (2015), 9779–9788.
24. 24 Dong, Y., Zhao, J., Wu, C.W., Zhang, L., Liu, X., Kang, W., et al. Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res. 11 (2013), 1051–1060.
25. 25 Cheng, Z., Liu, F., Wang, G., Li, Y., Zhang, H., Li, F., miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cell Signal. 26 (2014), 2667–2673.
26. 26 Tao, J., Wu, D., Xu, B., Qian, W., Li, P., Lu, Q., et al. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. Oncol Rep. 27 (2012), 1967–1975.
27. 27 Zhou, Y., Wu, D., Tao, J., Qu, P., Zhou, Z., Hou, J., MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. Scand J Urol. 47 (2013), 423–432.
28. 28 Zhang, X.T., Zhang, Z., Xin, Y.N., Ma, X.Z., Xuan, S.Y., Impairment of growth of gastric carcinoma by miR-133-mediated Her-2 inhibition. Tumour Biol. 36 (2015), 8925–8930.
29. 29 Xu, F., Li, F., Zhang, W., Jia, P., Growth of glioblastoma is inhibited by miR-133-mediated EGFR suppression. Tumour Biol., 2015.